Inventor · disambiguated record
Gerhard Sperl
Also filed as: SPERL GERHARD · SPERL GERHARD J
25 granted patents·3 pending applications·537 citations·filing 1994–2017
96Inventor score
Top patents by PatentIndex Score
28 records- 0196US6348032B1Method of inhibiting neoplastic cells with benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Feb 19, 2002·117 cites·2 claims
- 0287US6166053ASubstituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Dec 26, 2000·14 cites·2 claims
- 0387US5696159ALactone compounds for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1994·Granted Dec 9, 1997·35 cites·18 claims
- 0486US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 0586US6211177B1Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 3, 2001·86 cites·6 claims
- 0683US6420410B1Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-onesCELL PATHWAYS INC·Filed 2000·Granted Jul 16, 2002·17 cites·7 claims
- 0782US6403831B1Substituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 2000·Granted Jun 11, 2002·13 cites·1 claims
- 0882US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 0979US6300346B1Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 2000·Granted Oct 9, 2001·7 cites·16 claims
- 1076US5965619AMethod for treating patients having precancerous lesions with substituted indene derivativesCELL PATHWAYS INC·Filed 1997·Granted Oct 12, 1999·47 cites·29 claims
- 1174US6063818ASubstituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 1997·Granted May 16, 2000·32 cites·47 claims
- 1271US5948779ASubstituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydesCELL PATHWAYS INC·Filed 1997·Granted Sep 7, 1999·13 cites·77 claims
- 1370US6066634ASubstituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted May 23, 2000·12 cites·28 claims
- 1466US6071934AIndenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jun 6, 2000·25 cites·4 claims
- 1566US6028116ASubstituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Feb 22, 2000·29 cites·52 claims
- 1664US6121321ASubstituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1996·Granted Sep 19, 2000·26 cites·23 claims
- 1757US6160003A1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1999·Granted Dec 12, 2000·5 cites·18 claims
- 1852US6610854B2Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2002·Granted Aug 26, 2003·0 cites·2 claims
- 1945US5939417A1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Aug 17, 1999·2 cites·24 claims
- 2044US2008096903A1Sulfamoyl-containing derivatives and uses thereofWYETH CORP·Filed 2007·Application pending·0 cites
- 2144US2002082280A1Method of inhibiting neoplastic cells with benzimidazole derivativesFiled 2001·Application pending·0 cites
- 2243US5998477ASubstituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Dec 7, 1999·7 cites·40 claims
- 2340US10301324B2Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their useAtrin Pharmaceuticals LLC·Filed 2017·Granted May 28, 2019·0 cites·45 claims
- 2440US6455703B21,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Sep 24, 2002·0 cites·10 claims
- 2539US6426349B1Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAY AND THE UNIVERSIT·Filed 2000·Granted Jul 30, 2002·0 cites·4 claims
- 2639US2002028936A11,3-disubstituted indolin-2-ones for neoplasiaFiled 2001·Application pending·0 cites
- 2736US5776962ALactone compounds for treating patient with precancerous lesionsCELL PATHWAYS INC·Filed 1995·Granted Jul 7, 1998·3 cites·43 claims
- 2835US6020379APosition 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1999·Granted Feb 1, 2000·2 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Gerhard Sperl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →